Food Technology, engineering and Nutrition, LTH, Lund University
Lund, 22100, Sweden
NCT Number: NCT04439630
Postprandial effects of Nopal fractions on glucose and appetite regulation will be investigated in healthy humans, in a randomised controlled crossover trial
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Not applicable
Lund, 22100, Sweden
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Nopal flour were divided in two fractions and mixed in two different test breads
Test product without the active components
Time frame: 0-180 min after start of the meal
effects on postprandial glucose tolerance after intake of test products at breakfast. Measurements were performed at fasting (time = 0 min) and at 15, 30, 45, 60, 90, 120, 150 and 180 min.
Time frame: 0-180 min
effects on serum insulin concentrations after intake of test products at breakfast. Measurements were performed at fasting (time = 0 min) and at 15, 30, 45, 60, 90, 120, 150 and 180 min.
Time frame: 0-180 min
Subjective appetite variables (hunger, satiety, desire to eat) after intake of test products at breakfast, using a 100 mm Visual Analogue Scale (VAS) on a white paper. Except from a center mark in the center of the scale there was no other visible marks. Measurements were performed at fasting (time = 0 min) and at 15, 30, 45, 60, 90, 120, 150 and 180 min.
Lund University
Other
Evaluation of Potentially Bioactive Foods With Regard to Their Effects on Cardiometabolic Test Markers and Cognitive Variables
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07412730
Glucose Tolerance, Healthy Volunteers
Brisbane, Queensland, Australia
View Trial DetailsNCT00628524
Arterial Occlusive Diseases, Arteriosclerosis
Homburg, Saarland, Germany
View Trial DetailsNCT06193291
Glucose Tolerance, HRV
San Diego, California, United States
View Trial DetailsNCT04904133
Glucose Tolerance, Healthy Population
Istanbul, Anadolu, Turkey (Türkiye)
View Trial Details